Free Trial

Heatwurx (PCSA) Competitors

Heatwurx logo
$0.22 +0.03 (+14.55%)
As of 03:52 PM Eastern

PCSA vs. LSB, TLPH, DWTX, AEON, NLSP, CLRB, CHRO, KPRX, TSBX, and BMRA

Should you be buying Heatwurx stock or one of its competitors? The main competitors of Heatwurx include LakeShore Biopharma (LSB), Talphera (TLPH), Dogwood Therapeutics (DWTX), AEON Biopharma (AEON), NLS Pharmaceutics (NLSP), Cellectar Biosciences (CLRB), Chromocell Therapeutics (CHRO), Kiora Pharmaceuticals (KPRX), Turnstone Biologics (TSBX), and Biomerica (BMRA). These companies are all part of the "pharmaceutical products" industry.

Heatwurx vs. Its Competitors

Heatwurx (NASDAQ:PCSA) and LakeShore Biopharma (NASDAQ:LSB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Heatwurx has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, LakeShore Biopharma has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500.

Heatwurx has higher earnings, but lower revenue than LakeShore Biopharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HeatwurxN/AN/A-$11.85M-$3.08-0.07
LakeShore Biopharma$80.82MN/A-$61.09MN/AN/A

Heatwurx presently has a consensus target price of $2.00, indicating a potential upside of 800.90%. Given Heatwurx's stronger consensus rating and higher possible upside, analysts clearly believe Heatwurx is more favorable than LakeShore Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heatwurx
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
LakeShore Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Heatwurx had 6 more articles in the media than LakeShore Biopharma. MarketBeat recorded 8 mentions for Heatwurx and 2 mentions for LakeShore Biopharma. Heatwurx's average media sentiment score of 0.73 beat LakeShore Biopharma's score of 0.00 indicating that Heatwurx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heatwurx
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
LakeShore Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

LakeShore Biopharma's return on equity of 0.00% beat Heatwurx's return on equity.

Company Net Margins Return on Equity Return on Assets
HeatwurxN/A -319.56% -232.40%
LakeShore Biopharma N/A N/A N/A

91.9% of Heatwurx shares are held by institutional investors. Comparatively, 52.6% of LakeShore Biopharma shares are held by institutional investors. 9.6% of Heatwurx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Heatwurx beats LakeShore Biopharma on 9 of the 12 factors compared between the two stocks.

Get Heatwurx News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PCSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PCSA vs. The Competition

MetricHeatwurxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.64M$2.37B$5.47B$8.92B
Dividend YieldN/A1.78%5.24%4.04%
P/E Ratio-0.078.9227.0520.14
Price / SalesN/A501.68380.7693.83
Price / CashN/A21.7726.2128.59
Price / Book0.484.528.005.58
Net Income-$11.85M$31.26M$3.16B$248.40M
7 Day Performance11.00%6.11%3.84%6.13%
1 Month Performance-26.15%5.75%3.04%7.78%
1 Year Performance-86.21%1.24%34.26%20.95%

Heatwurx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PCSA
Heatwurx
3.6437 of 5 stars
$0.22
+14.6%
$2.00
+800.9%
-88.8%$2.64MN/A-0.0720
LSB
LakeShore Biopharma
0.3485 of 5 stars
$0.99
-0.4%
N/AN/A$9.26M$80.82M0.00773News Coverage
Positive News
Gap Up
TLPH
Talphera
1.6068 of 5 stars
$0.46
+2.7%
$5.00
+979.9%
-50.7%$9.25M$650K-1.0319
DWTX
Dogwood Therapeutics
1.1598 of 5 stars
$4.60
-4.2%
$10.00
+117.4%
N/A$9.17MN/A-0.255Positive News
AEON
AEON Biopharma
3.3607 of 5 stars
$0.79
-5.5%
$360.00
+45,371.8%
-98.9%$8.95MN/A4.405
NLSP
NLS Pharmaceutics
N/A$2.27
-7.0%
N/A+1,101.1%$8.78MN/A0.006Analyst Upgrade
CLRB
Cellectar Biosciences
3.3014 of 5 stars
$4.80
flat
$375.00
+7,712.5%
-93.3%$8.69MN/A-0.2210Gap Down
CHRO
Chromocell Therapeutics
N/A$1.34
+6.3%
N/A-89.1%$8.69MN/A-1.084Gap Up
High Trading Volume
KPRX
Kiora Pharmaceuticals
2.2816 of 5 stars
$2.81
-1.4%
$10.00
+255.9%
-38.8%$8.68MN/A-0.9710
TSBX
Turnstone Biologics
1.5715 of 5 stars
$0.37
+0.9%
$0.45
+23.3%
-83.7%$8.37MN/A-0.1382
BMRA
Biomerica
0.376 of 5 stars
$3.40
+4.0%
N/A-2.5%$8.32M$5.41M-1.4760

Related Companies and Tools


This page (NASDAQ:PCSA) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners